Novartis signs initial deal to manufacture Pfizer jabs

Friday, 29. January 2021 13:04

Novartis International AG announced on Friday the company has reached an initial agreement with Pfizer Inc. and BioNTech SE to provide manufacturing capacity for their COVID-19 vaccine.

The production in its plant located in Stein, Switzerland, is expected to start in the second quarter of the year, with the first deliveries estimated to commence in the following quarter. If the deal is finalized, it would contribute towards solving vaccine delivery issues that the European Union is currently facing.

"As a company reimagining medicine with advanced therapy platforms, we are committed to leverage our manufacturing capabilities to help support the supply of COVID-19 vaccines and therapeutics around the world. We expect this to be the first of a number of such agreements," commented Technical Operations Head Steffen Lang.

Related Links: BioNTech SEPfizer Inc.Novartis AG
Author:
Breaking the News / ND